You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK – Vividion Therapeutics said on Wednesday it has raised $135 million in a Series C financing round led by two new investors, Logos Capital and Boxer Capital of Tavistock Group.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.